David Stanton

Stock Analyst at Jefferies

(4.08)
# 1,715
Out of 5,134 analysts
252
Total ratings
43.7%
Success rate
9.9%
Average return

Stocks Rated by David Stanton

Integral Diagnostics Limited
Oct 29, 2026
Reiterated: Buy
Price Target: $3.30 → $2.90
Current: $1.65
Upside: +75.76%
Sigma Healthcare Limited
Oct 21, 2026
Reiterated: Buy
Price Target: $3.20 → $3.15
Current: $2.90
Upside: +8.62%
Telix Pharmaceuticals Limited
Oct 21, 2026
Reiterated: Buy
Price Target: $32.00 → $31.50
Current: $13.39
Upside: +135.25%
Pro Medicus Limited
Oct 20, 2026
Reiterated: Hold
Price Target: $196.95 → $199.00
Current: $201.66
Upside: -1.32%
Mesoblast Limited
Oct 16, 2026
Reiterated: Buy
Price Target: $2.90 → $2.80
Current: $1.89
Upside: +48.54%
Ramsay Health Care Limited
Oct 13, 2026
Reiterated: Hold
Price Target: $48.50 → $49.85
Current: $54.95
Upside: -9.28%
CSL Limited
Oct 6, 2026
Reiterated: Hold
Price Target: $146.50 → $161.50
Current: $202.52
Upside: -20.25%
Healius Limited
Sep 25, 2026
Reiterated: Hold
Price Target: $0.41 → $0.44
Current: $0.58
Upside: -24.14%
Immutep Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $0.04 → $0.08
Current: $0.02
Upside: +233.33%
Monash IVF Group Limited
Sep 1, 2026
Reiterated: Buy
Price Target: $0.83 → $0.80
Current: $0.73
Upside: +9.59%
Reiterated: Buy
Price Target: $40.80 → $39.30
Current: $7.59
Upside: +417.79%
Reiterated: Buy
Price Target: $29.40 → $28.90
Current: $22.98
Upside: +25.76%
Reiterated: Hold
Price Target: $128.40 → $144.75
Current: $150.83
Upside: -4.03%
Reiterated: Hold
Price Target: $23.00 → $21.00
Current: $19.98
Upside: +5.11%
Reiterated: Buy
Price Target: $5.00 → $5.60
Current: $1.83
Upside: +206.85%
Downgraded: Hold
Price Target: n/a
Current: $12.45
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $13.39
Upside: n/a